Ledger.Open graph →
SEC Form D · filed April 1, 2025

PIROUETTE PHARMA INC

Offering
$3.5M
Sold
$2.4M
Exemption
Rule 506(c)
Industry
Pharmaceuticals
Location
PORTSMOUTH, NH
Type
—

Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.

People & firms on this filing (15)

Parinaz Motamedy · Portsmouth, NHDirectorElijah Kapas · ARLINGTON, MAExec · PromoterMatthew Kane · DURHAM, NCExec · Director · PromoterConor Cullinane · Portsmouth, NHExec · Director · PromoterJoseph Nemmers · San Diego, CADirectorParinaz Motamedy · Portsmouth, NHDirectorElijah Kapas · ARLINGTON, MAExec · PromoterMatthew Kane · DURHAM, NCExec · Director · PromoterConor Cullinane · Portsmouth, NHExec · Director · PromoterJoseph Nemmers · Westborough, MADirectorJoseph Gasik · Houston, TXDirectorRobert Bailey · Houston, TXExec · PromoterMd Shafiqul Islam · CAMBRIDGE, United KingdomExec · Director · PromoterKatharine Marsh · SALT LAKE CITY, UTExec · Director · PromoterGalit A. Flasterstein · San Jose, G2Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗